Filing Details
- Accession Number:
- 0001203311-22-000008
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-01 18:42:58
- Reporting Period:
- 2022-01-28
- Accepted Time:
- 2022-02-01 18:42:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seagen Inc. | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1202335 | W David Gryska | 21823 30Th Drive Se Bothell WA 98021 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-01-28 | 850 | $20.06 | 47,100 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-01-28 | 850 | $121.69 | 46,250 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-01-28 | 2,553 | $20.06 | 48,803 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-01-28 | 2,553 | $122.43 | 46,250 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-01-28 | 883 | $20.06 | 47,133 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-01-28 | 883 | $123.39 | 46,250 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-01-28 | 214 | $20.06 | 46,464 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-01-28 | 214 | $124.23 | 46,250 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-01-28 | 850 | $0.00 | 850 | $20.06 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-01-28 | 2,553 | $0.00 | 2,553 | $20.06 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-01-28 | 883 | $0.00 | 883 | $20.06 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-01-28 | 214 | $0.00 | 214 | $20.06 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 12,150 | 2022-05-17 | No | 4 | M | Direct | |
| 9,597 | 2022-05-17 | No | 4 | M | Direct | |
| 8,714 | 2022-05-17 | No | 4 | M | Direct | |
| 8,500 | 2022-05-17 | No | 4 | M | Direct |
Footnotes
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $120.99 to $121.96. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $122.03 to $122.97. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $123.04 to $124.03. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $124.13 to $124.29. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Options were fully vested on 5/17/13.
Billionaire Hedge Funds
